(BN) Danone - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000120644
BN: Dairy, Plant-Based, Nutrition, Waters, Beverages
Danone S.A. is a global leader in the food and beverage industry, operating across over 40 countries worldwide. The company is organized into three core segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Its product portfolio spans a wide range of categories, including yogurts, dairy products, plant-based alternatives, specialized nutrition formulas, and mineral waters. Danone has established a strong presence in both developed and emerging markets, with a focus on health-conscious consumers and sustainable practices.
The company distributes its products under a diverse portfolio of brands, including Activia, Actimel, evian, Volvic, Alpro, Aptamil, and Nutricia, among others. These brands cater to various consumer needs, from everyday nutrition to specialized medical and infant feeding solutions. Danones distribution network includes retail chains, convenience stores, hotels, restaurants, pharmacies, and e-commerce platforms, ensuring broad accessibility to its products.
Danone S.A. has a long history, dating back to its incorporation in 1899. The company, formerly known as Groupe Danone, rebranded to its current name in April 2009. Headquartered in Paris, France, Danone has positioned itself as a key player in the global food industry, with a market capitalization of approximately €47.3 billion as of the latest data. The companys commitment to innovation, sustainability, and health-focused products has enabled it to maintain a competitive edge in a rapidly evolving market landscape.
Additional Sources for BN Stock
BN Stock Overview
| Market Cap in USD | 54,324m |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| GiC Sub-Industry | Packaged Foods & Meats |
| IPO / Inception |
BN Stock Ratings
| Growth Rating | 55.6 |
| Fundamental | 62.5 |
| Dividend Rating | 63.0 |
| Rel. Strength | 20.7 |
| Analysts | - |
| Fair Price Momentum | 81.61 EUR |
| Fair Price DCF | 150.34 EUR |
BN Dividends
| Dividend Yield 12m | 6.04% |
| Yield on Cost 5y | 8.22% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 99.2% |
BN Growth Ratios
| Growth Correlation 3m | 85.7% |
| Growth Correlation 12m | 89.4% |
| Growth Correlation 5y | 68% |
| CAGR 5y | 7.81% |
| CAGR/Max DD 5y | 0.29 |
| Sharpe Ratio 12m | 0.93 |
| Alpha | 25.45 |
| Beta | -0.208 |
| Volatility | 21.86% |
| Current Volume | 1855.2k |
| Average Volume 20d | 1816.3k |
As of May 01, 2025, the stock is trading at EUR 75.96 with a total of 1,855,208 shares traded.
Over the past week, the price has changed by +2.21%, over one month by +7.23%, over three months by +12.57% and over the past year by +34.23%.
Yes, based on ValueRay Fundamental Analyses, Danone (PA:BN) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 62.52 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BN as of May 2025 is 81.61. This means that BN is currently overvalued and has a potential downside of 7.44%.
Danone has no consensus analysts rating.
According to ValueRays Forecast Model, BN Danone will be worth about 88.1 in May 2026. The stock is currently trading at 75.96. This means that the stock has a potential upside of +16.03%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 73.5 | -3.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 88.1 | 16% |